The RAPID Reserve Act is designed to enhance the reliability of the supply chain for essential medications and their active ingredients, particularly to prevent shortages during public health emergencies or other crises. The legislation establishes a program allowing the Secretary of Health and Human Services to award contracts to eligible entities that maintain a six-month reserve of critical drugs and their ingredients. These entities are required to produce these drugs as directed and may need to transfer some of their reserves to other manufacturers if necessary.